Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Sonoma Pharmaceuticals, Inc. (SNOA) had Return on Tangible Equity of -14.10% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$5.60M |
|
$-0.53M |
|
$3.48M |
|
$2.12M |
|
$5.94M |
|
$-0.34M |
|
$-0.39M |
|
$-0.73M |
|
$-0.73M |
|
$-0.53M |
|
$-0.53M |
|
$-0.53M |
|
$-0.53M |
|
$-0.34M |
|
$-0.30M |
|
1.65M |
|
1.65M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$12.50M |
|
$0.28M |
|
$1.35M |
|
$13.86M |
|
$4.32M |
|
-- |
|
$5.75M |
|
$10.07M |
|
$3.79M |
|
$3.79M |
|
$3.79M |
|
1.65M |
|
| Cash Flow Statement Financials | |
$-2.65M |
|
$-0.12M |
|
$-0.12M |
|
$5.37M |
|
$3.04M |
|
$-2.34M |
|
$0.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.89 |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
37.83% |
|
-6.01% |
|
-6.01% |
|
-- |
|
-13.04% |
|
-9.53% |
|
$-2.77M |
|
-- |
|
-- |
|
-- |
|
0.40 |
|
0.96 |
|
2.07 |
|
43.41 |
|
-14.10% |
|
|
Return on Tangible Equity |
-14.10% |
-3.85% |
|
-14.10% |
|
$2.30 |
|
$-1.68 |
|
$-1.61 |
|